Recombinant Human Biotinylated FGL1 (C-Fc-Avi)

Cat.No.: CY19

Description
Recombinant Human Fibrinogen-like Protein 1 is produced by our Mammalian expression system and the target gene encoding Leu23-Ile312 is expressed with a Fc, Avi tag at the C-terminus.
Accession #:Q08830
Known as:Fibrinogen-like protein 1; FGL1; HP-041; Hepassocin; HFREP-1; LFIRE-1
Formulation
Lyophilized from a 0.2 μm filtered solution of PBS, 5% trehalose, pH7.4.
Quality Control
Purity:Greater than 90% as determined by reducing SDS-PAGE.
BioActivity:Immobilized Mouse LAG-3-His(Cat#CK56) at 2μg/ml (100 μl/well) can bind Biotinylated Human FGL1-Avi(Cat#CY19).
Endotoxin:Less than 0.1 ng/
Reconstitution
Always centrifuge tubes before opening. Do not mix by vortex or pipetting.
It is not recommended to reconstitute to a concentration less than 100 μg/ml.
Dissolve the lyophilized protein in ddH2O.
Please aliquot the reconstituted solution to
Storage
Lyophilized protein should be stored at < -20°C, though stable at room temperature for 3 weeks.
Reconstituted protein solution can be stored at 4-7°C for 2-7 days.
Aliquots of reconstituted samples are stable at < -20°C for 3 months.
Background
Fibrinogen-like protein 1(FGL1) is also known as HP-041, Hepassocin, HFREP-1, LFIRE-1, is a liver-specific secreted protein belonging to the fibronogen superfamily, whose members share a fibrinogen domain at their C-termini. It is secreted by the liver and functions as a mitogen for hepatocytes. Hepassocin may play a role in the development of hepatocellular carcinomas. Hepassocin is a disulfide-linked homodimeric protein with a C-terminal fibrinogen domain. It is reported that it is a major immune inhibitory ligand of LAG-3 .

Send Message